Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamethasone (D-VTd) VS VTd In Transplant-Eligible NDMM

Philippe Moreau, MD Of Nantes Faculty of Medicine Discusses Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamet​hasone (D-VTd) VS VTd In Transplant-Eligi... Author: Annual-Meeting Added: 06/02/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts